The incidence and risk of second primary cancers in patients with nasopharyngeal carcinoma: a population-based study in Taiwan over a 25-year period (1979-2003)

被引:49
作者
Chen, M. -C. [2 ,3 ]
Feng, I. -J. [4 ]
Lu, C. -H. [1 ,5 ]
Chen, C. -C. [1 ,5 ]
Lin, J. -T. [1 ,5 ]
Huang, S. -H. [2 ,3 ]
Lee, K. -D. [1 ,5 ]
机构
[1] Chang Gung Mem Hosp, Dept Hematol & Oncol, Pu Tz City 613, Chiayi, Taiwan
[2] Chang Gung Univ, Sch Med, Dept Publ Hlth, Tao Yuan, Taiwan
[3] Chang Gung Univ, Sch Med, Biostat Consulting Ctr, Tao Yuan, Taiwan
[4] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA
[5] Chang Gung Inst Technol, Dept Nursing, Chiayi, Taiwan
关键词
cumulative incidence; nasopharyngeal carcinoma; second primary cancer;
D O I
10.1093/annonc/mdn003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Very few reports are available on the incidence and risk of second primary cancers in nasopharyngeal carcinoma (NPC) cases, and most of these are single-institution reviews with relatively small case numbers and short follow-up. Patients and methods: A population-based study was conducted. We quantified standardized incidence ratios (SIRs) and cumulative incidence of second cancers among 23 639 individuals with initial diagnoses of NPC. Results: We found a 24% increased risk of second cancers in NPC patients compared with the general population [SIR = 1.24, 95% confidence interval 1.15-1.33]. Elevated SIRs were observed in the following second primary cancers: oral/pharyngeal, salivary gland, sarcoma, skin and leukemia/lymphoma. The cumulative incidence > 10 years was 3.26%. The risk was higher in younger patients, especially those < 40 years old. After diagnosis of second cancers, the median survival time was 1.7 years. Conclusions: This is the largest population-based study to date from a high-incidence area. We found that NPC is associated with an increased risk of second malignancies, which had a negative impact on the survival of patients who survived NPC.
引用
收藏
页码:1180 / 1186
页数:7
相关论文
共 31 条
  • [1] Second cancers are killing us!
    Alberts, David S.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (11) : 2019 - 2019
  • [2] ARMSTRONG RW, 1983, CANCER RES, V43, P2967
  • [3] Breslow N E, 1987, IARC Sci Publ, P1
  • [4] CHOY ATK, 1992, CANCER, V70, P815, DOI 10.1002/1097-0142(19920815)70:4<815::AID-CNCR2820700416>3.0.CO
  • [5] 2-Q
  • [6] COOPER JS, 1991, CANCER-AM CANCER SOC, V67, P1673, DOI 10.1002/1097-0142(19910315)67:6<1673::AID-CNCR2820670632>3.0.CO
  • [7] 2-1
  • [8] Day G L, 1994, Eur J Cancer B Oral Oncol, V30B, P381, DOI 10.1016/0964-1955(94)90016-7
  • [9] *DEP HLTH, 2001, CANC REG ANN REP
  • [10] Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4
    Feng, BJ
    Huang, W
    Shugart, YY
    Lee, MK
    Zhang, F
    Xia, JC
    Wang, HY
    Huang, TB
    Jian, SW
    Huang, P
    Feng, QS
    Huang, LX
    Yu, XJ
    Li, D
    Chen, LZ
    Jia, WH
    Fang, Y
    Huang, HM
    Zhu, JL
    Liu, XM
    Zhao, Y
    Liu, WQ
    Deng, MQ
    Hu, WH
    Wu, SX
    Mo, HY
    Hong, MF
    King, MC
    Chen, Z
    Zeng, YX
    [J]. NATURE GENETICS, 2002, 31 (04) : 395 - 399